• Efficacy and safety of roluperidone versus drug combination in adults with schizophrenia with negative symptoms

    Recruiting

    3 1 1
    Investigated Drugs:
    Bulgaria Romania

  • Efficacy and safety of oral semaglutide for weight loss in adults with overweight or obesity

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Denmark France Greece The Netherlands +3

  • Efficacy and Safety of BAY 3670549 in Adults with Atrial Fibrillation: A Randomized, Double‑Blind, Placebo‑Controlled Phase 2 Study

    Recruiting

    2 1
    Belgium Bulgaria Germany Hungary Italy The Netherlands +1

  • Phase 2 Study Evaluating OV329 on Photo‑Induced EEG Response in Adults with Epilepsy

    Recruiting

    2 1
    Investigated Diseases:
    The Netherlands

  • A Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Germany Poland

  • Phase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis

    Recruiting

    2 1
    Investigated Diseases:
    Bulgaria Denmark France Germany Greece Hungary +4

  • Resistance Training to Preserve Thigh Muscle Volume in Adults with Obesity Treated with Tirzepatide (Phase IV Randomized Trial)

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Germany

  • A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

    Recruiting

    3 1 1
    Investigated Drugs:
    Czechia Denmark Germany Greece Hungary Poland +1

  • Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +9

  • Efficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia Denmark France +11

powered by